Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjögren's syndrome

Lupus

Volumn 17, Issue 3, 2008, Pages 228-229

  Sánchez Cano, Daniel ^a   Callejas Rubio, J L ^a   Lara Jimenez M A ^a   Lopez Trascasa M ^b   Circadi, M ^c   Ortego Centeno, N ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DANAZOL; IMMUNOGLOBULIN M; RITUXIMAB; RO ANTIBODY; STEROID; TRANEXAMIC ACID;

AGED; ANGIONEUROTIC EDEMA; CASE REPORT; CLINICAL FEATURE; COMPLEMENT COMPONENT C1 INHIBITOR DEFICIENCY; COMPLEMENT DEFICIENCY; DRUG MEGADOSE; FEMALE; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; SJOEGREN SYNDROME; TACHYCARDIA;

AGED; ANGIOEDEMA; ANTIBODIES, MONOCLONAL; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; SJOGREN'S SYNDROME;

EID: 42549083360     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307087405     Document Type: Letter

References (5)

1. Markovic, SN, Inwards, DJ, Frigas, EA, Phyliky, RP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000; 132: 144-150.
2. Zingale, LC, Castelli, R, Zanichelli, A, Cicardi, M. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006; 26: 669-690.
3. Ziakas, PD, Giannouli, S, Psimenou, E, Evangelia, K, Tzioufas, AG, Voulgarelis, M. Acquired angioedema: a new target for rituximab? Haematologica 2004; 89: ELT13.
4. Levi, M, Hack, CE, van Oers, MH. Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med 2006; 119: e3-5.
5. Sneller, MC. Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment? Arthritis Rheum 2005; 52: 1-5.